Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study.
Thamlikitkul L, Srimuninnimit V, Akewanlop C, Ithimakin S, Techawathanawanna S, Korphaisarn K, Chantharasamee J, Danchaivijitr P, Soparattanapaisarn N. Thamlikitkul L, et al. Among authors: akewanlop c. Support Care Cancer. 2017 Feb;25(2):459-464. doi: 10.1007/s00520-016-3423-8. Epub 2016 Oct 6. Support Care Cancer. 2017. PMID: 27714530 Clinical Trial.
Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy.
Ithimakin S, Theeratrakul P, Laocharoenkiat A, Nimmannit A, Akewanlop C, Soparattanapaisarn N, Techawattanawanna S, Korphaisarn K, Danchaivijitr P. Ithimakin S, et al. Among authors: akewanlop c. Support Care Cancer. 2020 Nov;28(11):5335-5342. doi: 10.1007/s00520-020-05380-6. Epub 2020 Mar 4. Support Care Cancer. 2020. PMID: 32128615 Clinical Trial.
Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study.
Archwamety A, Teeyapun N, Siripoon T, Poungvarin N, Tanasanvimon S, Sirachainan E, Akewanlop C, Korphaisarn K. Archwamety A, et al. Among authors: akewanlop c. Front Oncol. 2022 Feb 15;12:813009. doi: 10.3389/fonc.2022.813009. eCollection 2022. Front Oncol. 2022. PMID: 35242708 Free PMC article.
Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Prospective Observational Cohort Study.
Thanestada J, Srinonprasert V, Nimmannit A, Korphaisarn K, Pramyothin P, Akewanlop C. Thanestada J, et al. Among authors: akewanlop c. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221106529. doi: 10.1177/15330338221106529. Technol Cancer Res Treat. 2022. PMID: 35695243 Free PMC article.
Cost-Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand.
Phisalprapa P, Kositamongkol C, Korphaisarn K, Akewanlop C, Srimuninnimit V, Supakankunti S, Apiraksattayakul N, Chaiyakunapruk N. Phisalprapa P, et al. Among authors: akewanlop c. Cancers (Basel). 2023 Oct 11;15(20):4930. doi: 10.3390/cancers15204930. Cancers (Basel). 2023. PMID: 37894297 Free PMC article.
32 results